Recent News

• 09.17.2025 - TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
• 09.17.2025 - TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.03.2025 - TScan Therapeutics to Participate in Upcoming Investor Conferences
• 09.03.2025 - TScan Therapeutics to Participate in Upcoming Investor Conferences
• 08.12.2025 - TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.12.2025 - TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

• 09.09.2025 - 8-K Current report
• 09.09.2025 - EX-99.1 EX-99.1
• 08.22.2025 - 3 Initial statement of beneficial ownership of securities
• 08.20.2025 - 8-K Current report
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - 8-K Current report
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors